标题
Metastatic and triple-negative breast cancer: challenges and treatment options
作者
关键词
Liposomes, EGFR, siRNA, Gefitinib, Combinatorial treatment of breast cancer
出版物
Drug Delivery and Translational Research
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-07-06
DOI
10.1007/s13346-018-0551-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non-surgical management of triple-negative breast cancer
- (2018) R. F. D. van la Parra et al. BRITISH JOURNAL OF SURGERY
- Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
- (2018) Christiana Neophytou et al. Frontiers in Oncology
- Vascular Invasion in Triple-Negative Carcinoma of the Breast Identified by Endothelial Lymphatic and Blood Vessel Markers
- (2017) Hajime Kuroda et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies
- (2016) Lin Ye et al. CANCER LETTERS
- Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis
- (2016) Zhiyong Ren et al. PATHOLOGY RESEARCH AND PRACTICE
- Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer
- (2016) Domenico Ribatti et al. Translational Oncology
- Relation of Pre-anthracycline Serum Bilirubin Levels to Left Ventricular Ejection Fraction After Chemotherapy
- (2015) Trinity Vera et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of Age, Tumor Size, Lymph Node Metastasis, Stage, Receptor Status and Menopausal Status on Overall Survival of Breast Cancer Patients in Pakistan
- (2015) Humera Mahmood et al. Asian Pacific Journal of Cancer Prevention
- Breast cancer metastasis burden in sentinel nodes analysed using one-step nucleic acid amplification predicts axillary nodal status
- (2015) Thomas D. Milner et al. BREAST
- The prognostic impact of age in different molecular subtypes of breast cancer
- (2015) Cornelia Liedtke et al. BREAST CANCER RESEARCH AND TREATMENT
- Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer
- (2015) Zhaomei Mu et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
- (2015) D J A Lobbezoo et al. BRITISH JOURNAL OF CANCER
- Tumeurs secondaires : incidence, facteurs de risque et recommandations de prévention
- (2015) Charlotte Demoor-Goldschmidt et al. BULLETIN DU CANCER
- Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
- (2015) Edgardo Rivera et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer
- (2015) A. M. Grawenda et al. CANCER RESEARCH
- Pattern of metastasis and outcome in patients with breast cancer
- (2015) L. Gerratana et al. CLINICAL & EXPERIMENTAL METASTASIS
- Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery
- (2015) Colin T. Murphy et al. Clinical Breast Cancer
- Brain Metastasis and Response to Ado-Trastuzumab Emtansine: A Case Report and Literature Review
- (2015) Richa Kalsi et al. Clinical Breast Cancer
- Functional Studies on Viable Circulating Tumor Cells
- (2015) K. Pantel et al. CLINICAL CHEMISTRY
- Breast Cancer Under Age 40: a Different Approach
- (2015) D. Ribnikar et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure
- (2015) Kazuhiro Araki et al. EXPERT OPINION ON PHARMACOTHERAPY
- Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy
- (2015) Chuanli Ren et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of genomic signatures in circulating tumor cells from breast cancer
- (2015) Nisha Kanwar et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer
- (2015) Carolyn S. Hall et al. JNCI-Journal of the National Cancer Institute
- Prophylactic Administration of Fucoidan Represses Cancer Metastasis by Inhibiting Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinases (MMPs) in Lewis Tumor-Bearing Mice
- (2015) Tse-Hung Huang et al. Marine Drugs
- Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes
- (2015) Taghipour Zahir Shokouh et al. MEDICINE
- MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells
- (2015) LEI YU et al. ONCOLOGY REPORTS
- Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis
- (2015) Seongseok Yun et al. POSTGRADUATE MEDICAL JOURNAL
- Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
- (2015) Zhengquan Han et al. World Journal of Surgical Oncology
- Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling
- (2015) Lynn Feys et al. Oncotarget
- Trends in presentation, management and survival of patients with de novo metastatic breast cancer in a Southeast Asian setting
- (2015) Nirmala Bhoo-Pathy et al. Scientific Reports
- Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer
- (2015) Carolyn S. Hall et al. JNCI-Journal of the National Cancer Institute
- Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies
- (2015) Joyce O’Shaughnessy et al. SpringerPlus
- Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer
- (2015) Serena Bertozzi et al. SpringerPlus
- Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
- (2015) Linda M. McInnes et al. Frontiers in Oncology
- Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer
- (2015) Ga-Eon Kim et al. BMC CANCER
- Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer
- (2014) K. C. Patel et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Risk Factors for the Development of Uterine Cancer in Breast Cancer Survivors: An Army of Women Study
- (2014) Diogo Torres et al. ANNALS OF SURGICAL ONCOLOGY
- Taxanes
- (2014) Lohith S. Bachegowda et al. ANTI-CANCER DRUGS
- Current Progress in the Treatment of Metaplastic Breast Carcinoma
- (2014) Qing Hu et al. Asian Pacific Journal of Cancer Prevention
- Effect of Lymphangiogenesis and Lymphovascular Invasion on the Survival Pattern of Breast Cancer Patients
- (2014) Pradyumna Kumar Sahoo et al. Asian Pacific Journal of Cancer Prevention
- Medical Treatment of Breast Cancer Bone Metastasis: From Bisphosphonates to Targeted Drugs
- (2014) Bulent Erdogan et al. Asian Pacific Journal of Cancer Prevention
- Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
- (2014) Isabell Witzel et al. BMC CANCER
- Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer
- (2014) Fadia J A Gujam et al. BMC CANCER
- Trastuzumab in advanced breast cancer – a decade of experience in Germany
- (2014) Christian Jackisch et al. BMC CANCER
- A phase 1/2 of a combination of Cetuximab and Taxane for “triple negative” breast cancer patients
- (2014) Hovav Nechushtan et al. BREAST
- A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
- (2014) A. Lintermans et al. BREAST CANCER RESEARCH AND TREATMENT
- Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series
- (2014) Vincent Sibaud et al. BREAST CANCER RESEARCH AND TREATMENT
- Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer
- (2014) Claudette Falato et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer
- (2014) Wolfgang Janni et al. BREAST CANCER RESEARCH AND TREATMENT
- Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy
- (2014) Y Chavarri-Guerra et al. BRITISH JOURNAL OF CANCER
- Immunohistochemical Study of Apoptotic Marker p53 as a Prognostic Factor in Breast Cancer
- (2014) K. S. Loskutova et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
- (2014) Ji Soo Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer
- (2014) E. Kontopodis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficacy of biological agents in metastatic triple-negative breast cancer
- (2014) Annalisa Bramati et al. CANCER TREATMENT REVIEWS
- The Levels of Ki-67 Positive are Positively Associated with Lymph Node Metastasis in Invasive Ductal Breast Cancer
- (2014) Yongxiang Yin et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The Safety of Concentrated Trastuzumab in 100 ml of Saline Solution for Administration to Patients with HER2-Positive Breast Cancer: A Phase 1 Study
- (2014) Norihiko Sengoku et al. CHEMOTHERAPY
- The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration
- (2014) Mehmet A.N. Sendur et al. CURRENT MEDICAL RESEARCH AND OPINION
- Breast cancer during follow-up and progression – A population based cohort on new cancers and changed biology
- (2014) E. Karlsson et al. EUROPEAN JOURNAL OF CANCER
- Vandetanib as a potential treatment for breast cancer
- (2014) Antonella De Luca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New protein kinase inhibitors in breast cancer: afatinib and neratinib
- (2014) Xiaosong Zhang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer
- (2014) Hidemi Kawajiri et al. Expert Review of Anticancer Therapy
- Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer Patients
- (2014) Jung Sun Kim et al. Journal of Breast Cancer
- Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group
- (2014) Amye J. Tevaarwerk et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive, Locally Advanced, or Metastatic Breast Cancer
- (2014) Kathy D. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Neratinib in Combination With Capecitabine in Patients With Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2014) Cristina Saura et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and Optimization of Novel Hydroxamate-Based Histone Deacetylase Inhibitors of Bis-Substituted Aromatic Amides Bearing Potent Activities against Tumor Growth and Metastasis
- (2014) Feifei Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP
- (2014) Giulio Di Minin et al. MOLECULAR CELL
- Effectiveness of Trastuzumab in First-Line HER2+ Metastatic Breast Cancer After Failure in Adjuvant Setting: A Controlled Cohort Study
- (2014) E. Negri et al. ONCOLOGIST
- Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
- (2014) Angela Alistar et al. Genome Medicine
- Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer
- (2014) Tao Zhang et al. NEOPLASIA
- Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer
- (2014) Jessica M Baron et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting
- (2014) G Dranitsaris et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer
- (2013) Marissa Howard-McNatt et al. AMERICAN JOURNAL OF SURGERY
- Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
- (2013) J. Crown et al. ANNALS OF ONCOLOGY
- Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer
- (2013) J. Cortés et al. ANNALS OF ONCOLOGY
- Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases: a Preferential Option for Triple Negative Patients?
- (2013) Cigdem Erten et al. Asian Pacific Journal of Cancer Prevention
- The metastatic microenvironment of breast cancer: Clinical implications
- (2013) R.E. Coleman et al. BREAST
- Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients
- (2013) Kyung Lan Ko et al. BREAST CANCER RESEARCH AND TREATMENT
- Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
- (2013) H Iwase et al. BRITISH JOURNAL OF CANCER
- Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer
- (2013) L W-C Chow et al. BRITISH JOURNAL OF CANCER
- All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer
- (2013) Hesham Tawfik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study
- (2013) Rachel C. Jankowitz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer
- (2013) Rachel M. Layman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer
- (2013) Paul L. McCormack DRUGS
- Daidzein, R-(+)equol and S-(−)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2
- (2013) Pamela J. Magee et al. EUROPEAN JOURNAL OF NUTRITION
- Transarterial chemoembolisation (TACE) with gemcitabine: Phase II study in patients with liver metastases of breast cancer
- (2013) Katrin Eichler et al. EUROPEAN JOURNAL OF RADIOLOGY
- Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer
- (2013) Alessandra Fabi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Optimal tolerability and high efficacy of a modified schedule of lapatinib–capecitabine in advanced breast cancer patients
- (2013) T. Gamucci et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Treatment of Triple-Negative Breast Cancer Using Anti-EGFR-Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor
- (2013) F. Al-Ejeh et al. JOURNAL OF NUCLEAR MEDICINE
- Breast cancer: Current and future endocrine therapies
- (2013) Carlo Palmieri et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis
- (2013) Sandra M. Saldana et al. PLoS One
- EGFR and microvessel density in canine malignant mammary tumours
- (2013) Maria Isabel Carvalho et al. RESEARCH IN VETERINARY SCIENCE
- A luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancer
- (2013) Kimihiro Tanaka et al. SURGERY TODAY
- Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol
- (2013) Amit Goyal et al. World Journal of Surgical Oncology
- Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology
- (2013) Muhammet Ali Kaplan et al. Breast Cancer
- First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: Cost-minimization analysis
- (2013) Virginie Nerich et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
- (2013) Binnaz Demirkan Journal of Clinical Medicine
- Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy
- (2012) A. Awada et al. ANNALS OF ONCOLOGY
- A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
- (2012) Martin Schuler et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
- (2012) Nancy U. Lin et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast
- (2012) Adele A. Bailes et al. CANCER
- A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer
- (2012) N. Karachaliou et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?
- (2012) Jian Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- A Phase I Study of Capecitabine, Oxaliplatin, and Lapatinib in Metastatic or Advanced Solid Tumors
- (2012) Trevor W. Dennie et al. Clinical Colorectal Cancer
- Triple Negative Breast Cancer: From Molecular Portrait to Therapeutic Intervention
- (2012) Pietro Carotenuto et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
- (2012) Rupert Bartsch et al. EUROPEAN JOURNAL OF CANCER
- Field cancerization in mammary carcinogenesis — Implications for prevention and treatment of breast cancer
- (2012) Ashley G. Rivenbark et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Strategies for the discovery and development of therapies for metastatic breast cancer
- (2012) Bedrich L. Eckhardt et al. NATURE REVIEWS DRUG DISCOVERY
- Grape Polyphenols Inhibit Akt/Mammalian Target of Rapamycin Signaling and Potentiate the Effects of Gefitinib in Breast Cancer
- (2012) Linette Castillo-Pichardo et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines
- (2012) M. WAHEED ROOMI et al. ONCOLOGY REPORTS
- Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad
- (2012) Nicole K. Nickerson et al. PLoS One
- Matrix metalloproteinases: Potential therapy to prevent the development of second malignancies after breast radiotherapy
- (2012) F. Artacho-Cordón et al. SURGICAL ONCOLOGY-OXFORD
- Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya
- (2012) Eramah Ermiah et al. Journal of Cancer
- Management of patients with metastatic breast cancer
- (2011) Josefina Cruz Jurado et al. ADVANCES IN THERAPY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
- (2011) G. Somlo et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
- (2011) H J Stemmler et al. BRITISH JOURNAL OF CANCER
- The prognostic significance of lymphovascular invasion in invasive breast carcinoma
- (2011) Emad A. Rakha et al. CANCER
- Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1
- (2011) J. McBryan et al. CANCER RESEARCH
- Oral vinorelbine in metastatic breast cancer: A review of current clinical trial results
- (2011) Matti Aapro et al. CANCER TREATMENT REVIEWS
- A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study
- (2011) C. Villanueva et al. EUROPEAN JOURNAL OF CANCER
- Mechanisms of cancer cell metastasis to the bone: a multistep process
- (2011) Lalit R Patel et al. Future Oncology
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Conjugate of Gemcitabine With Bisphosphonate (Gem/BP) Shows Potential as a Targeted Bone-Specific Therapeutic Agent in an Animal Model of Human Breast Cancer Bone Metastases
- (2011) A. A. El-Mabhouh et al. ONCOLOGY RESEARCH
- Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
- (2011) Jan Rykala et al. PATHOLOGY & ONCOLOGY RESEARCH
- Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
- (2011) Kunal S. Taskar et al. PHARMACEUTICAL RESEARCH
- Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
- (2011) Abderrahim El Guerrab et al. PLoS One
- Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?
- (2011) Yvonne H.-F. Teng et al. Recent Patents on Anti-Cancer Drug Discovery
- Expression of human mammaglobin as a marker of bone marrow micrometastasis in breast cancer
- (2011) YUNJIANG LIU et al. Experimental and Therapeutic Medicine
- Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer
- (2010) X. S. Chen et al. ANNALS OF ONCOLOGY
- Biological Mechanisms Linking Obesity and Cancer Risk: New Perspectives
- (2010) Darren L. Roberts et al. Annual Review of Medicine
- Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
- (2010) Florence Ragage et al. CANCER
- Prospective Study of Vinorelbine and Capecitabine Combination Therapy in Chinese Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
- (2010) Ying Fan et al. CHEMOTHERAPY
- Systemic treatment in breast-cancer patients with brain metastasis
- (2010) Cagatay Arslan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Characteristics of triple-negative breast cancer
- (2010) Tim C. de Ruijter et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
- (2010) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Factors for Reproductive and Breast Cancers among Older Lesbians
- (2010) Eve Zaritsky et al. JOURNAL OF WOMENS HEALTH
- Risk factors for brain relapse in HER2-positive metastatic breast cancer patients
- (2009) Renata Duchnowska et al. BREAST CANCER RESEARCH AND TREATMENT
- Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
- (2009) E-M Boneberg et al. BRITISH JOURNAL OF CANCER
- The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2
- (2009) M. Jager et al. CANCER RESEARCH
- Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes
- (2009) Daniel Chan et al. INVESTIGATIONAL NEW DRUGS
- Down-regulation of uPA and uPAR by 3,3′-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells
- (2009) Aamir Ahmad et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane(R)) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
- (2008) V. Roy et al. ANNALS OF ONCOLOGY
- Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
- (2008) Maura N. Dickler et al. BREAST CANCER RESEARCH AND TREATMENT
- Systemic Spread Is an Early Step in Breast Cancer
- (2008) Yves Hüsemann et al. CANCER CELL
- Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor
- (2008) N. K. Saxena et al. CANCER RESEARCH
- A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer
- (2008) Juan Lucas Bayo-Calero et al. Clinical Breast Cancer
- Ertumaxomab: a trifunctional antibody for breast cancer treatment
- (2008) Philipp Kiewe et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search